Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,995
Closed -$833K 264
2023
Q1
$833K Buy
2,995
+1,555
+108% +$430K 0.21% 134
2022
Q4
$399K Buy
1,440
+969
+206% +$274K 0.11% 171
2022
Q3
$126K Buy
+471
New +$100K 0.06% 261

Other funds holding BIIB

Exos TFP Holdings's BIIB Position: Q2 2023 in Review

Exos TFP Holdings sold out of Biogen (BIIB) in Q2 2023, closing a stake of 2,995 shares — an estimated $833K sold.

Exos TFP Holdings first reported a position in BIIB in Q3 2022 and held it in 3 quarters. The position peaked at $833K in Q1 2023. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • Exos TFP Holdings reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 2,995 Biogen shares in Q2 2023, an estimated $833K.
  • Exos TFP Holdings first reported a position in Biogen in Q3 2022 and held it in 3 quarters.
  • Exos TFP Holdings's Biogen position peaked at $833K in Q1 2023.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Exos TFP Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.